Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
deferasirox (exjade) (1 trial)
abiraterone (zytiga) (1 trial)
prednisone (meticorten) (1 trial)
beta-Thalassemia (Phase 2)
Prostatic Neoplasms (Phase 1)
Thalassemia (Phase 2)
Trials (2 total)
Trial APIs (3 total)